Previous Article | Next Article ![]()
Journal of Virology, December 2001, p. 12058-12069, Vol. 75, No. 24
Department of Medicine, University of
Cambridge, Addenbrooke's Hospital, Cambridge CB2 2QQ, United Kingdom
Received 23 March 2001/Accepted 3 August 2001
Deletion of a region of the human immunodeficiency virus type 2 (HIV-2) 5' leader RNA reduces genomic RNA encapsidation to about 5%
that of wild-type virus with no defect in viral protein production but
severely limits virus spread in Jurkat T cells, indicating that this
region contains a major cis-acting encapsidation signal,
or psi (
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.24.12058-12069.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
The Major Human Immunodeficiency Virus Type 2 (HIV-2) Packaging
Signal Is Present on All HIV-2 RNA Species: Cotranslational RNA
Encapsidation and Limitation of Gag Protein Confer
Specificity
and
). Being upstream of the major splice donor, it is present
on all viral transcripts. We have shown that HIV-2 selects its genomic
RNA for encapsidation cotranslationally, rendering wild-type HIV-2
unable to encapsidate vector RNAs in trans . Virus with
deleted, however, encapsidates an HIV-2 vector, demonstrating competition for Gag protein. HIV-2 overcomes the lack of packaging signal location specificity by two novel mechanisms, cotranslational packaging and competition for limiting Gag polyprotein.
*
Corresponding author. Mailing address: Department of
Medicine, University of Cambridge, Level 5, Addenbrooke's Hospital,
Hills Rd., Cambridge CB2 2QQ, United Kingdom. Phone: 44-223 336747. Fax: 44-223 336846. E-mail:
amll1{at}mole.bio.cam.ac.uk.
Previously Jane F. Kaye.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|